Bausch + Lomb announced plans to bring its recalled enVista intraocular lenses (IOLs) back to the market after resolving the issue that led to a

Elon Musk’s Neuralink is reportedly looking to raise $500 million at a pre-money valuation of $8.5 billion, as it continues to make strides in the

Biolinq has secured $100 million in Series C funding to further develop its biosensor platform, which includes the first intradermal glucose sensor that integrates activity